BIOLINERX LTD-SPONS ADR (BLRX) Stock Income Statement
NASDAQ:BLRX - Nasdaq - US09071M2052 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 22.34M | 28.94M | 4.80M | 0.00 | 0.00 | |||
| Cost Of Goods | 7.84M | 9.26M | 3.69M | N/A | N/A | |||
| Gross Profit | 14.50M | 19.68M | 1.11M | N/A | N/A | |||
| Operating Expenses | 31.46M | 39.08M | 44.10M | 29.16M | 24.78M | |||
| Research and Development | 8.28M | 8.72M | 11.94M | 17.01M | 18.81M | |||
| Selling, General, and Administrative Expenses | 23.19M | 29.59M | 31.23M | 11.49M | 5.27M | |||
| Operating Income | -16.97M | -19.40M | -42.99M | -29.16M | -24.78M | |||
| Interest Income/Expense | -7.01M | -7.20M | -76.00K | -1.44M | -425.00K | |||
| Other Income/Expense | 21.59M | 18.39M | -10.84M | 5.64M | -1.85M | |||
| Non Recurring Items | N/A | -1.01M | -6.70M | N/A | N/A | |||
| Income Before Taxes | -3.40M | -9.22M | -60.61M | -24.95M | -27.05M | |||
| Net Income | -3.40M | -9.22M | -60.61M | -24.95M | -27.05M | |||
| EBITDA | -13.63M | -15.33M | -41.61M | -28.50M | -24.07M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.74 | -4.59 | -37.49 | -19.19 | -24.32 | |||
| Statistics | ||||||||
| Gross Profit Margin | 64.90% | 67.99% | 23.08% | N/A | N/A | |||
| Profit Margin | -15.21% | -31.86% | -1262.79% | N/A | N/A | |||
| Operating Profit Margin | -75.95% | -67.03% | -895.65% | N/A | N/A | |||
All data in USD